Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study 2 based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA Documento uri icon

  •  
  • Visão geral
  •  
  • Pesquisas
  •  
  • Identidade
  •  
  • Informação adicional documento
  •  
  • Outro
  •  
  • Ver todos
  •